Literature DB >> 28736376

[Protective effects of glycyrrhizic acid against lupus nephritis in MRL/lpr mice].

Yuan-Yuan Wang1, Hong-Tao Li, Yang Lu, Xiao-Yun Jia, Yang-Lei Li, Sheng Chen, Ji-Xia Chai, Jia-Jia Zhang, Dong Liu, Chang-Hao Xie.   

Abstract

OBJECTIVE: To investigate protective effect of glycyrrhizic acid (GA) against lupus nephritis in MRL/lpr mice and explore its underlying mechanisms.
METHODS: Forty MRL/lpr mice were randomized equally into blank control group, dexamethasone (1.5 mg/kg) group, GA (20 mg/kg) group, and GA (40 mg/kg) group with corresponding treatments for 7 days, with 10 wild-type mice as the control group. Serum levels of uric acid and creatinine and inflammatory cytokines in the serum and kidney were tested after the treatments using enzyme-linked immunosorbent assays (ELISA). The pathological changes in the kidneys were detected using HE staining, and the protein expressions of NLRP3, ASC, caspase-1, IL-1β, p-NF-κB, NF-κB, p-IκBα, and IκBα were detected with Western blotting.
RESULTS: GA obviously decreased serum levels of uric acid and creatinine, decreased inflammatory cytokines in the serum and kidney, ameliorated renal pathologies and inhibited the expressions of NLRP3, ASC, caspase-1, IL-1β, p-NF-κB, and p-IκBα proteins in MRL/lpr mice.
CONCLUSION: GA has protective effects against lupus nephritis in MRL/lpr mice.

Entities:  

Year:  2017        PMID: 28736376      PMCID: PMC6765503     

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  23 in total

1.  P2X7 blockade attenuates murine lupus nephritis by inhibiting activation of the NLRP3/ASC/caspase 1 pathway.

Authors:  Jijun Zhao; Hongyue Wang; Chao Dai; Hongyang Wang; Hui Zhang; Yuefang Huang; Shuang Wang; Felicia Gaskin; Niansheng Yang; Shu Man Fu
Journal:  Arthritis Rheum       Date:  2013-12

2.  Reagent- and separation-free measurements of urine creatinine concentration using stamping surface enhanced Raman scattering (S-SERS).

Authors:  Ming Li; Yong Du; Fusheng Zhao; Jianbo Zeng; Chandra Mohan; Wei-Chuan Shih
Journal:  Biomed Opt Express       Date:  2015-02-19       Impact factor: 3.732

Review 3.  Inflammasomes: mechanism of action, role in disease, and therapeutics.

Authors:  Haitao Guo; Justin B Callaway; Jenny P-Y Ting
Journal:  Nat Med       Date:  2015-06-29       Impact factor: 53.440

4.  The NLRP3 inflammasome is a potential target of ozone therapy aiming to ease chronic renal inflammation in chronic kidney disease.

Authors:  Gang Yu; Zhiming Bai; Zhiyuan Chen; Hui Chen; Guoren Wang; Gang Wang; Zhenxiang Liu
Journal:  Int Immunopharmacol       Date:  2016-12-27       Impact factor: 4.932

5.  Bay11-7082 attenuates murine lupus nephritis via inhibiting NLRP3 inflammasome and NF-κB activation.

Authors:  Jijun Zhao; Hui Zhang; Yuefang Huang; Hongyue Wang; Shuang Wang; Chunmei Zhao; Yingjie Liang; Niansheng Yang
Journal:  Int Immunopharmacol       Date:  2013-06-12       Impact factor: 4.932

6.  Demethylzeylasteral (T-96) Treatment Ameliorates Mice Lupus Nephritis Accompanied by Inhibiting Activation of NF-κB Pathway.

Authors:  Qiongyi Hu; Chunxin Yang; Qiang Wang; Haiying Zeng; Wanzhang Qin
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

7.  Methylprednisolone attenuates lipopolysaccharide-induced Fractalkine expression in kidney of Lupus-prone MRL/lpr mice through the NF-kappaB pathway.

Authors:  Yanwu You; Yueqiu Qin; Xu Lin; Fafen Yang; Jun Li; Suren R Sooranna; Liao Pinhu
Journal:  BMC Nephrol       Date:  2015-08-27       Impact factor: 2.388

8.  Glycyrrhizic Acid Attenuates Sepsis-Induced Acute Kidney Injury by Inhibiting NF-κB Signaling Pathway.

Authors:  Hongyu Zhao; Min Zhao; Yu Wang; Fengchun Li; Zhigang Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2016-01-24       Impact factor: 2.629

Review 9.  Pathogenic Inflammation and Its Therapeutic Targeting in Systemic Lupus Erythematosus.

Authors:  Timothy A Gottschalk; Evelyn Tsantikos; Margaret L Hibbs
Journal:  Front Immunol       Date:  2015-10-28       Impact factor: 7.561

10.  Glycyrrhetinic acid alleviates radiation-induced lung injury in mice.

Authors:  Jinmei Chen; Weijian Zhang; Lurong Zhang; Jiemin Zhang; Xiuying Chen; Meichun Yang; Ting Chen; Jinsheng Hong
Journal:  J Radiat Res       Date:  2016-09-26       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.